Detalles de la búsqueda
1.
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
N Engl J Med;
386(24): 2273-2282, 2022 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704479
2.
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Cancer;
130(6): 985-994, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37962072
3.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer;
130(10): 1747-1757, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236702
4.
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer.
Cancer;
128(20): 3602-3609, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947048
5.
Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy.
Cancer;
128(3): 536-546, 2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614209
6.
Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials.
Cancer;
128(14): 2728-2735, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35578919
7.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med;
380(25): 2395-2405, 2019 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31157962
8.
Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors.
Breast Cancer Res Treat;
194(2): 337-351, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35633421
9.
Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
Ann Surg Oncol;
29(13): 8016-8023, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900648
10.
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
Blood;
136(11): 1284-1297, 2020 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32430507
11.
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trial.
Cancer;
127(14): 2545-2552, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33793979
12.
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Cancer;
127(24): 4546-4556, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726788
13.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med;
379(2): 111-121, 2018 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860917
14.
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Breast Cancer Res Treat;
188(2): 477-487, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852121
15.
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Radiology;
301(1): 66-77, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34342501
16.
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.
Haematologica;
106(3): 730-735, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32107337
17.
Clinical Utility of 18F-FDG PET/CT in Staging Localized Breast Cancer Before Initiating Preoperative Systemic Therapy.
J Natl Compr Canc Netw;
18(9): 1240-1246, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886897
18.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med;
373(21): 2005-14, 2015 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26412349
19.
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply.
N Engl J Med;
381(13): 1290-1291, 2019 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553846
20.
A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104).
Breast Cancer Res Treat;
165(2): 375-382, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28623430